Relay Therapeutics' financial stability is strong, but zero Q3 2024 revenue and rising net losses raise concerns. Find out ...

The allocation of N35.75 billion for capital expenditure in the 2025 Appropriation Bill to the Ministry of Marine and Blue Econom ...

WASHINGTON (AP) — In a major reversal, the new head of the Environmental Protection Agency said he will try to rescind $20 ...

Aardvark’s lead candidate ARD-101 is being investigated in a Phase III study for hyperphagia in Prader-Willi syndrome.

Health scientists and drug industry executives around the world are on alert after the confirmation of Robert F. Kennedy Jr., who spreads antivaccine misinformation and has often derided the ...

Nuvation has a best-in-class lung cancer drug that could be approved in the US in June. Read why I'm bullish on the stock ...

With Robert F. Kennedy Jr. set to be sworn in as HHS secretary later Thursday, one of the first tasks in his new position will be to implement some of the ideas spelled out in his "Make America Health ...

Moleculin Biotech received FDA guidance reducing its Phase 3 trial size for Annamycin in AML. First unblinding is expected in ...

Researchers at Umeå University have recently developed a highly sensitive method for detecting bacterial spores—tough ...

U.S. investors and large pharmaceutical companies are increasingly doing deals in China as the country’s biopharma sector ...